Mount Sinai Opens Psychedelics Research Center
A new facility for psychedelics research, the Center for Psychedelic Psychotherapy and Trauma Research, was recently opened in New York City. The center follows a multifaceted research and clinical approach to finding new and more effective treatments for anxiety, depression, PTSD and other conditions linked to stress in both the civilian and veteran populations. The facility’s research will center on the study of psilocybin, MDMA and other psychedelic substances. MDMA, which is commonly known as ecstasy, is a psychoactive drug that may be used as a PTSD therapy treatment. Earlier in 2017, the U.S. FDA granted Breakthrough Therapy Designation status…